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I . INTRODUCTION S BRIEF REVIEW OF DIABETES MELLITUS (DM) 
Diabetes mellltus i s a genetically determined disorder 
of the metabolism of carbohydrate, protein and fats associated with 
a relat ive or absolute insufficiency of insulin secretion and with 
various degrees of insulin resistance, in which the level of blood 
glucose i s persistently raised above the normal range. 
This disease is heterogenous in nature. Differences 
between various forms of the disease are expressed in terms of 
etiology and pathogenesis (genetic, environmental and immune 
factors), natural history and response to treatment. Diabetes 
therefore i s not a single disease but a syndrome. 
I (a) Classification of DM : 
In most classifications including that of National Diabetes 
Data Group (NDDG), diabetes mellitus has been divided into two 
major categories : 
( i ) Insulin dependent diabetes melUtus (IDDM) or Juvenile onset 
diabetes or Type I diabetes. 
( i i) Non-insuUn dependent diabetes mellltus (NIDDM) or Maturity 
onset diabetes or Type II diabetes. 
(i) IDDM : This i s known as juvenile onset diabetes melUtus 
because i t usually occurs in the young though i t may occur 
at any age and often shows second peak of incidence in 60-
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70 age group. There appears to be a seasonal variation in incidence 
In younger patients, highest in winter months and lov/est in the 
summer. Cell mediated immunity may bo present against pancreatic 
antigens and positive pancreatic islet cell bodies (ICA) occur in 
over 80 per cent of patients at diagnosis. Certain human leucocytes 
antigens (HLA), also known as histocompatibility antigens, may 
determine the susceptibility to developing Type I DM. Following 
two types of HLA groupings Increase the risk : 
(1) Al, Cw7, B8 or BIB, Dw3, DRw3 
(2) A2, Cw3, B15 or B40, Dw4, DRw4 
On the other hand the grouping A3, B7, Dw2 and DRv;! 
Is associated with a low risk. 
In some Instances viruses e .g . coxsackie B4, mumps 
and rubella, may act as a stimulus to an autoimmune destruction 
of B-cel ls . In others primary autoimmune mechanisms may be 
responsible and the diabetes melUtus may occur in association with 
other autoimmune disorders. 
(11) NIP DM : This is known as maturity onset DM because it occurs 
usually after 40 years of age. Obesity is suspected as an 
etiological factor and on this basis type II DM has two subclasses-
nonobese and obese - non-lnsuUn - dependent diabetics. There is 
no proven association with a viral etiology, autoimmunity or HLA 
type although Identical twin studies show a strnns genntic 
relationship. Some patients initially classified as type II DM nuiy 
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subsequently develop type I DM. These subjects often have a 
persistence of ICA and a family history of type I DM. In addition, 
type II diabetics may require insulin temporarily during s t ress . 
A comparison of the main differences in two types of diabotes 
mellitus i s presented below 
Comparison of IDDM (type I) and NIDDM (type II) 
Features 
Age at onset 
Peak incidence 
Proportion of all 
diabetics 
Seasonal trend 
Appearance of 
symptoms 
Obesity at onset 
Ketoacidosis 
Number of p-cel ls 
Insulin Secretion 
Inflammatory Cells 
in Islets 
Association with 
autoimmune disease 
Antlpancreatlc 
Cell-mediated 
Immunity 
Antibodies to 
Islet cells 
Insulin dependent 
Usually <40 years 
12-14 years 
25 percent 
Autumn and winter 
Acute or subacute 
Uncommon 
Usual 
Decreased 
Decreased 
Present Initially 
Frequent 
40-50 per cent 
at onset 
60-80 per cent 
at onset 
Non-insulin dependent 
Mostly >40 years 
Rises with age 
75 percent 
None 
Slow 
Common 
Rare 
Variable 
Variable 
Absent 
Chance association 
< 5 per cent 
< 5 per cent 
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Concordance ' 50 per cent 100 per cent 
in identical 
twins 
HLA association Yes No 
I (b) Prevalence of DM In Different Populations 
(i) ID DM : 
Prevalence of IDDM is very low compared to that of 
NIDDM. Among the individuals of 30 years or even younger it does 
not usually exceed 0.3%. 
( i i ) NIDDM : 
NIDDM is the most common of hyperglycemic states 
affecting 1-5% of total population. The prevalence i s highest in 
the Pima Indians of Arizona (>40%). A high prevaloice rates for 
Indians has been estimated in a large study conducted in western 
part of India, the prevalence rates obtained were the highest among 
Asian Countries. 
In a collaborative study involving six widely separated 
Centres in India conducted between 1972 and 1975 (Ahuja, 1979), 
the overall prevalence of diabetes was 1.8%, with higher rate 2.1% 
in the urban than in the rural areas (1.5%). The overall rates in 
, / • • 
males (2.3%) were greater than 1n females^, with the rnalf^  
predominance more apparent in the urban than in the rural aroas. 
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In teres ting ly, diabetes was more prevalent in vegetarians (2.1-2.6'^) 
than among non vegetarians (<2%). A marked association between 
income and diabetes prevalence was seen and differences were foard 
according to occupational status. It was found to be 10% in 
professionals and less than 1% in unskilled labourers. There was 
Increased prevalence with Increasing obesity and greater proportion 
of urban population was obese. 
I (c) Etiologic or Predisposing Factors in DM or Causes of DM : 
( i) Hereditary; 
There is a tendency for diabetes to run in families. 
The inheritance i s polygenic or multifactorial rather than by a 
simple mendeUan dominant or recessive mechanism. 
( i i ) Age : 
Diabetes becomes more common as age advances. 
( i i i ) Obesity : 
There is a strong association between obesity and 
diabetes. Plasma insulin levels are elevated in obese inciividuals 
and this i s probably related to insensitivity of the adipose tissue 
to the action of insulin. Obese individuals have to produce more insulin 
than those of ideal weight to preserve normal glucose tolerance. 
( iv) Infection : 
Pancreatitis following mumps, congenital rubella and 
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coxsackie B . infections are known to be followed by diabetes. 
Raised titers of antibodies to these viruses have been demonstrated. 
(v) Autoimmunity : 
Diabetes has been associated with many autoimmune 
disorders. In addition lymphocytic infiltration of the islet cells 
has been demonstrated in diabetes, hence it has been postulated 
that diabetes Is an autoimmune disease. 
(vl) Trace Elemgits : 
Deficiency of certain trace elements like Zinc and 
Chromium are known to occur in diabetes. 
I (d) Symptoms and pathophysiology of DM 
Whai pancreas does not provide adeq\iate insulin, glucose 
i s not conveyed from extracellular fluid Into the cel ls , and the 
cells without glucose to metabolize, become depleted of energy. 
To compensate for the lack of glucose, the c e l l s ' begin to oxidize 
fats and proteins from adipose tissue and muscle. This tissue 
breakdown causes wasting of muscle and tissue as well as ketosis 
(because of fat breakdown). 
The glucose that the cel l i s unable to use begins to accumulate 
in the blood, raising the blood sugar level (hyperglycaemia). At 
this stage, the strong osmotic pull of glucose draws fluid from tho 
cel ls , which causes cellular dehydration. When the blood glucose 
reaches 160 to 180 mg/100 ml, the kidneys begin to excrete the 
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glucose, which carries water with i t , resulting in symptoms of 
polyuria and glycosuria, dehydration and polydipsia (increased 
thirst) . 
Weight loss occurs because of the utilization of stored fat and 
protein for energy. Excessive hunger (polyphagia) is also 
experienced because glucose, although present cannot be used by 
the cells, and the use of body tissue instead results lin a state 
of starvation. 
I (e) Diagnosis of DM 
Once the diabetes i s suspected it can be confirmed by 
the following tests: 
( i) Urine Glucose Measurements : 
Traditionally glycosuria has been the screening test for 
DM because of widespread availability of simple specific tests for 
glucose in urine. The finding of heavy glycosuria is to all intents 
and purposes i s the diagnostic of the condition although good clinical 
practice dictates that the inevitable accompanying hyperglycemia 
should be documented with at least one rel iable blood glucose 
measuremait. 
(11) Blood Glucose Measurements : 
Blood at room temperature loses ± 7 mg glucose/100 ml 
per hour owing tcT^glycoly^s In red blood cells; at 4°C the loss 
'is ± 2 mg/100 ml pier—horn*. Because of this time related fall in 
glucose levels in whole blood samples, it should be centrifuged as 
soon as possible to separate of red blood cells . If it is necessary 
to compare whole blood with plasma, 15% correction should be 
made. This i s because of lower glucose concentration oi the red 
cells in relationship to their volume. 
Venous blood is usually employed for diagnosis of DM. 
In fasting state ilevels of blood glucose in arterial blood are only 
2-3 mg% above those of venous blood. However after the ingestion 
or injection of glucose, .values may be 20-70 mg% higher in capillary 
than the venous blood. Capillary blood glucose approximates that 
of arterial blood. 
( i i i ) Fasting Plasma Glucose : 
The normal fasting glucose level in venous plasma is 
between 60 6 115 mg/100 ml. Values above 120 mg/100 ml, when 
confirmed, are usually considered diagnostic of diabetes although 
NIH data group suggests 140 mg/100 ml as a more conservative value 
to use. There i s a reasonable agreement that persistent fasting 
hyperglycemia in the absence of complicating illness is sufficient 
for a diagnosis of diabetes. 
Reliance on the fasting glucose for diagnostic purposes 
has the advantage that most other transient metabolic disorders 
interfering with carbohydrate metabolism do not usually produce 
fasting hyperglycemia in otherwise normal individuals. 
(iv) Postprandial blood sugar test : 
It measures the blood sugar following a meal. Blood 
i s drawn 2 hrs after a meal of approximately 100 gm of 
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carbohydrate has been eaten. The glucose level at the end of 
2 hrs should be down to a normal of 80-100 mg./lOO ml. If 
i t exceeds 120 mg/100 ml, i t i s diagnostic of diabetes. 
(v) Oral Glucose Tolerance Test (OGTT) : 
It determines the response to a given amount of 
glucose. Three days prior to testing, a high carbohydrate diet 
i s given. Patient then fast for 12 h r s . Fasting blood S urine 
samples are collected, and then 100 gm of glucose is given by 
mouth. 
Blood and urine specimens are collected at 1/2, 1, 
2, 3, 4 and 5 hours after glucose is given. In normal individual, 
blood sugar r i ses rapidly in 1 hour to a peak of 140 to 150 
mg/100 ml, then drops to normal in 2-3 hours. In the diabetic, 
blood sugar continues to r ise for 2 to 3 hours and does not return 
to normal for 3 to 4 hours. All urine specimens are positive 
in the diabet ic . 
Certain stimulants, drugs and excerclse can affect the 
results of th is t e s t . 
(vi) Intravenous Glucose Tolerance Test (IVGTT) : 
This test provides the glucose load intravenously and 
is thus less physiologic than the oral glucose tolerance test . 
-10-
Besldes the fact, that food enters via the gastrointestinal 
hormones, stimulated by glucose entry in the gut, have significant 
effects on insulin secretion and action. In addition, the IVGTT 
is less sensitive than the OGTT, since the glucose load generally 
used is much less than that given for the oral tes t . On the other 
hand, the test may be advantageous in individuals in whom 
gastrointestinal disturbances interfere with normal glucose 
absorption or in whom nausea and vomitting interfere with the 
performance of the oral tes t . The IVGTT has been used in many 
research studies, because it i s more reproducible from OGTT, 
because of var iable of avoidance of gastrointestinal absorptions. 
(vi i ) Hemoglobin A. : 
The major component of human hemoglobin i s hemoglobin 
A, v/hose protein component globln has the structure O^^ * ^2. • 
On cation exchange chromatography, hemolysates of human red 
blood cells reveal one major component HbAg and four minor 
hemoglobin components, HbA. , HbA, , HbA,, and HbA, - collec-
t ively labelled as HbA, or glycosylated hemoglobin (GHb). HbA, 
i s the most abundant of these minor components. In HbA, a glucose 
molecule i s attached to the N-terminal amino group of the B-chain, 
the process represents a postranslational nonenzymatic modification 
of HbA within the red blood cells occuring continuously throughout 
the life span of R.B.C. in the circulation. In th is nonenzymatic 
glycosylatloii, glucose condenses' with the N-terminal valine of 
the •^-chain of hemoglobin to a degree determined by the level 
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of plasma glucose in a two stage chemical process. The first 
v/hich results in an aldamlne base is revers ib le , but the second 
involves rearrangement into a stable ketoamine. 
When the plasma glucose i s chronically elevated, the 
degree of glyoosylation provides an index as to the average 
glucose level over the half life of erythrocytes i . e . about 2 
mcnths (Koeing and Cerami, 1980). In the db/db mouse, after 
a transient period of polyphagia and obesity, t h e pancreas 
part ial ly fails and the animal develops the classical sign of DM. 
It i s generally assumed that hemoglobin A^ usually increases 4 weeks 
after the onset of hyperglycemia. Similar observations have been 
made in chemically induced diabetes with alloxan and 
streptozotocin. Thus the values of glycosylated hemoglobin reflect 
the average blood glucose concentration over a p r io r 2-3 month 
period and are increased 2-3 times in uncontrolled diabetics (Bunn 
et a l . ,1978; Jackson et a l . 1979; Gonan et a l . , 1977; Graft et a l . 
1978; Kennedy et a l . ,1979) . 
In normal subjects .HbA- ' makes up 3-6% of the total 
hemoglobin. In uncontrolled diabetics i t may be 6-12%. The 
measurement of HbA. for the diagnosis of DM has following 
advantages -
(1) I ts measurement shows better correlation to the degree 
of glycemic control in the management of diabetes 
mellltus than occasional periodic glucose estimation 
in blood or urine. 
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(2) It is an objective index independent of the pat ient ' s 
cooperation and reduces the measurement to a single 
test once in 2-3 mcnths. 
(3) It i s not affected by recent diet , excercise or acute 
s t r ess , which can cause wide variations in sequential 
blood glucose measurements. 
(4) I t may be especially valuable in monitoring pregnant 
d iabet ics . High levels of HbA. have been reported 
in diabetics giving bi r th to infants with foetal 
congenital abnormalities. 
(5) I t may be elevated in older patients with a raised 
renal threshold for glucose, in whom urine test may 
mistakenly suggest adequate control, 
(v i i i ) Insulin : , 
The hallmark of diabetes melUtus i s , ofcourse, a 
deficiency in insulin act iv i ty , most commonly the result of an 
absolute (type I) or relative (type II) lack of insulin. Insulin 
i s a polypeptide hormone secreted by the beta- is le ts of pancreas. 
Insulin has widespread effects on carbohydrate, lipid and protein 
metabolism. It accelerates the transport of glucose into the cells, 
resulting in an equilibrium of intra and extra cellular concentrations. 
In addition, insulin affects the intracellular metabolism of glucose. 
Insulin facilitates the movement of amino acids into cells and their 
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utilizatlon In protein synthesis, and the transport of Na and K 
ions across cel l walls. Decreased rates of protein synthesis 
resulting from inadequate insuKn levels affect normal growth. 
Lipogenesis in adipose and hepatic cel ls i s also amplified by 
insulin. Diabetes mellitus i s the result of insulin deficiency 
brought about e i ther by insufficient Insulin secretion or by rapid 
insulin cataboUsm. Impairement of the metabolic process affected 
by insulin causes decreased glucose utilization and increased 
glucogenesis, with much of the glucose wasted, leading to 
hyperglycemia. 
Insulin levels vary in diabetics but thei r determination 
i s important for the differentiation and diagnosis of various types 
of diabetes. 
I (f) Complications of DM : 
The vascular complications of diabetes mellitus fall 
into two categories, 
M icroangiopathy : 
It i s characterized by thickening of the basement 
membrane of capillary walls by glycoprotein deposits which may 
cause ischaemia (local anaemia produced by obstacles to the 
a r te r ia l flow). These include retinopathy, nephropathy and 
neuropathy. 
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M acroanglopathy : 
Which present clinically as coronary ar tery disease 
and cerebral vascular disease. 
Some important diabetic complications deserve further 
comments : 
( i ) Retinopathy : 
Diabetic retinopathy is a chronic progressive disease 
of the retina which leads to visual impairment and blindness. 
The prevalence of diabetic retinopathy is related to the age at 
onset and to the duration of the disease and those who have had 
diabetes the longest are most at r i s k . Other patients at r isk 
of developing diabetic retinopathy are those having evidence of 
microangiopathy elsewhere, especially renal disease e .g . patients 
with proteinuria. Retinopathy can be diagnosed by checking the 
fundus of the eye. 
(ii) Nephropathy : 
The term diabetic nephropathy describes the various 
pathological abnormalities in the kidney and their clinical 
consequences recognisable as a varying combination of proteinuria, 
oedema, hypertension, azotemia (moderate nitrogen retention 
accompanied by anaemia and resulting in generalized fatigue and 
weakness). and various renal vascular changes. 
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There is a thickening of glomeirular capillary basement 
membrane due to increased epi thel ia l synthesis of basement 
membrane or reduced destruction. The basement membrane like 
material accumulates in the mesangium and appears to change the 
basement membrane character is t ics , increasing i t s permeability 
to many plasma macro molecules. Since the mesangium appears to 
process glomerular basemoit membrane products, mesanglal 
dysfunction leads to a further piling up of glomerular basement 
membrane Uke material in the mesangium. Increasing permeability 
also allows the accumulation and deposition of fibrinogen and fibrin 
products in the mesangium and on the epi thel ia l aspects of the 
basement membrane. These deposits contribute to secondary 
capil lary closure. Ultimately increasing permeability is associated 
with proteinuria, although this may occur many years after the 
onset of th is thickening process. . 
At the light microscopic level these changes are 
reflected in three distinctive and overlapping lesions. All these 
lesions have an endpoint glomerular hyaUnization. As a 
consequence of these lesions, increasing number of glomeruli become 
hyalinlzed and shrunken and there may be secondary ischemic-
related periglomerular f ibrosis . 
In association with the glomerular changes there are 
important alterations in the ar ter iole , more importantly a hyaline 
lesion of efferent ar ter iole , although the affarent may be similarly 
involved. These lesions are sufficiently characterist ic to be of 
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aid in the diagnosis of diabetic kidney and functionally there 
may be impairmait of juxtraglomerular ce l l function, which may 
depress the secretion of enzyme renin. 
Proteinuria : Clinical proteinuria i s associated with increased 
mortality in people with insulin dependent diabetes mellitus 
(Anderson et a l . . 1983). This excess mortality is primarily 
attributed to uremia and cardiovascular d isease . (Borch-Johnsen 
et a l . . 1985; Jensen et a l . . 1987). Persistent proteinuria is also 
associated with increased mortality in noninsulin dependent 
diabetes melUtus (Nelson, et al.,1988). The death ra te in diabetic 
subjects with proteinuria increase by the concurrent presence of 
hypertension. Hypertension has been shown to contribute to the 
development of proteinuria in both NIDDM and IDDM subjects. 
Microalbuminuria : Albustix test for urinary protein excretion 
gives posit ive resul ts only when urinary albumin concentration 
and excretion is increased by a factor of approximately 20 from 
normal. More sensitive techniques have come into light recently 
which will detect early abnormalities in protein excretion termed 
ei ther 'subclinical proteinuria' or microalbuminuria. This 
microalbuminuria i s a strong predictor of future overt diabetic 
nephropathy. Diabetic patients devoid of microalbuminuria have 
only a small r i sk of developing cUnlcal proteinuria over the next 
10-14 years . 
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'Microalbuminuria' i s defined as abnormally elevated, 
urinary albumin excretion (or concentration) but without clinical 
proteinuria. The term was coined by Guy's Hospital Group in 
Lcndon (Viberti et a l . ,1982) , who in 1963 developed the first 
radioimmunoassay technique for detecting low concentration of 
albumin in urine. 
(iil) Neuropathy : 
Neuropathy i s a complication of diabetes due to 
involvement of per ipheral nerves especially sensory nerves, and 
chiefly affects the legs. It is about equally common in both 
sexes. The condition occurs more frequently with increasing age, 
is uncommon in adolescents and rare in children. Like other 
complications, neuropathy tends to be related to duration rather 
than severity of diabetes. 
MetaboUc and microangiopathic factors are important 
in the development of diabetic per ipheral neuropathy and affected 
nerves appear to be very sensitive to damage by minor trauma. 
Histologically the nerves show patchy segmental demyeUnation and 
axonal degeneration. The marked segmental demyeUnation is shown 
by var iabi l i ty of intemodal length as compared with axon 
diameter; this suggests that the primary disorder may be in the 
Schwan cells rather than in neurons itself. Nerve conduction rate 
ta ids to be impaired in most diabet ic . 
-18-
The res t of the nervous system i s not sparedofthe 
complicatiais of diabetes. The brain is affected by premature 
atherosclerosis and cerebral oedema may complicate prolonged 
hyperglycemia and severe ketoacidosis. 
Diabetes typically produces a sensory type of 
neuropathy, almost always confined to the lower limbs. 
(iv^ Atherosclerosis : 
Atherosclerosis t a ids to occur at an ear l ier age and 
with greater severity in .diabetic than in nondiabetic. It affects 
male and female equally. The lesions of atherosclerosis are 
characterized by intimal proliferation of smooth muscle cells , 
accumulation of large amounts of connective tissue matrix including 
collagen elastic fibers and deposition of intra and extracellular 
l ip id . The lesion is identical to those in nondiabetics but occurs 
at an ear l ier age as compared to nondiabetics. 
Despite enormous amount of investigations, the 
pathogenesis of the disease is not entirely clear and in fact there 
may well be a different balance of factors involved in different 
cases. 
There are many factors which have been implicated 
in increased tendency to atherosclerosis in diabetics, such as 
hyperglycemia, hyperlnsulinaemia, hyperlipidaemia, raised plasma 
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growth hormone levels and diverse abnormalities of coagulation. 
Many of them return to normal with improvement of diabetic 
contronl. 
Endothelial injury and lipid deposition seem to be 
an essential component of atherosclerosis . The quantitative 
association of atheropclerosis with diabetes mellitus is firmly 
establ ished, despi te the difficulty in understanding 
atherosclerosis . The association accounts for the 
disproportionately high Incidence of gangrene of the lower 
extremities and for coronary heart disease, the most important 
cause of death in diabetic patia:its. In an study glucose tolerance 
has been Identified as one of important factor contributing to a 
high r isk of cardiovascular disease. 
I (g) Recent Trends in the Management of DM : 
This includes advice on die t , exercise , oral 
hypoglycemic agents and insulin. 
( i) Diet : 
Diet forms the cornerstone in the treatment of 
diabetes. Basically, the diet of diabetic should be nutritionally 
balanced and should be planned so as to maintain a normal blood 
sugar. The current approach to low fat diet is aimed at 
prevention of atherosclerosis disease, not only controlling the 
blood sugar but also keeping the blood cholesterol and lipids 
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within normal l imits. In India experiaice with restr icted 
calories, high carbohydrate, low fat and high protein diet of 
Vishwanathan showed that i t was helpful in achieving effective 
control of diabetes . Low fat and high carbohydrate diet by 
maintaining normal lipid profile i s expected to lower the 
acceleration of atherosclerosis and thus reduce the incidence of 
cardiovascular complications. 
The purpose of incorporating high carbohydrate diet 
rich in fibre in diabetic meal plan to facilitate glycemic control 
and offers following advantages -
(1) It reduces postprandial hyperglycemia. 
(2) It allows reduction in insulin dosage. 
(3) Reduces levels of serum l ip ids , specially increases 
the levels of protective HDL cholesterol. 
( l i ) Oral Hypoglycemic Agents : 
They are of two types - sulfonylureas and biguanides. 
(1) Sulfonylureas : 
They stimulate the production and release of 
endogenous insuUn by beta cells of pancreas, and are prescribed 
for adult onset diabetics who are 40 years old and have been 
diabetic for less than 10 years and are not controlled by die t . 
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(2) Biguanides : 
Their mode of action is not clear, they are capable 
of lowering the blood sugar in the absence of a functioning 
pancreas. Biguanides block the pathways of glycolysis and 
enhance anaerobic glycolysis and increase lactic acid levels in 
the blood, also lower serum cholesterol and t r iglycerides . 
( i i i ) Exercise : 
Physical excercise i s one of the key factor in 
controlling diabetes, for successful treatment depends on 
establishing and maintaining a balance between insulin action, food 
intake and physical act ivi ty . Regular, regulated excercise help 
to increase glucose utilization. It helps to attain ideal weight. 
It tones up the body and improves circulation. It helps in 
building stamina and provides a sense of well being, 
(iv ) Insulin ;' 
Insulin is not a cure for diabetes but is used to help 
in management of the condition. It can be administered 
hypodermically and intravenously. Insulin being a protein, will 
be digested in the stomach if taken ora l ly . The action of insulin 
i s to keep down the blood sugar level by facilitating the transfer 
of glucose across the cel l membrane and by inhibiting the 
conversion of fats, proteins and glycogen into glucose. 
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InsuUn are divided into different groups related to 
the i r speed of action. 
(1) Rapid acting : Crystalline zinc insulin (regular insulin) 
: Semilente insuHn. 
(2) Intermediate acting : Globin zinc insulin 
: Neutral protamine Hagedorn insulin (NPH) 
: Lraite insuUn 
(3) Slow acting : Protamine zinc insulin (PZI) 
: Ultralente insulin 
All of these insulins function basically the same; they 
differ in time of the onset of action, time of peak action and 
duration of action. 
Newer Insulins : Local reactions of insulin are due to noninsulin 
materials and the general reactions are due to the insulin molecule 
proper . 
The newer insulin preparations have the merit of 
greater stabil i ty and lower concentration of zinc. Their neutral 
pH promotes rapid absorption. Insulin Actrapid is a quick acting 
pork insulin closely resembling human insulin In structure while 
Insulin Rapitard i s a suspaision of pure insulin with Actrapid 
insulin. 
In 1975, a highly purified soluble insulin of porcine 
origin was made. It was designated as Mcnocomponent insuUn. 
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InsuUn contains lot of impurities (proinsulin) and these are 
capable of binding to insulin in v i t ro . Insulin when repeatedly 
crystallized becomes less allergenic, but yet i t produces 
antibodies, whereas mcnocomponent insulin does not produce 
significant antibodies. 
Single peak insulin contains aspar t ic acid instead of 
aspargine at the terminal amino acid of the A chain. Single 
component insulin i s single peak insulin further purified by 
chromatography. 
The amount of insulin required are highly variable 
and dependent on individual needs. A juvenile diabetic i s more 
b r i t t l e and needs more insulin than a mature onset diabet ic . 
InsuHn requirements may also increase with serious i l lness, 
Infections, surgery and trauma. 
I (h) Prospective Management Techniques of DM : 
Several group of investigators, experimenting primarily 
with animals, have been exploring new techniques for providing 
a method of supplementing Insulin on a near-physiological level. 
Pancreas and beta cell transplants, implantation of an insulin -
infusion device and using a portable infusion pump are some of 
the new methods being researched. 
The concept of treating diabetes by transplantation 
of the pancreas started many years even before the discovery 
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of insulin. It has been shown that the transfer of isolated islet 
cell tissue between ra ts from inbred strains can reverse 
streptozotocin induced diabetes. Also i t can further delay or 
postpone nephropathy, developed in such animals. This prompted 
the search for methods in which is let tissue or cultured p-ce l l 
might be effectively implanted in human diabetic subjects. In 
animals various forms of functioning grafts have been used. 
(1) Transplantation of is le ts to various sites including 
peritoneal cavity and spleen. Neonatal is le ts are preferred 
because of rapid multiplication. 
(2) Transfer of foetal pancreas as a whole. 
(3) Imbolisation of prepared is le ts into the portal vein. 
(4) Implantation of cultured is lets into the spleen. 
(5) Placing of animal is le t tissue or p-ce l l s cultured in 
art if icial capillary units. 
These attempts resulted in ini t ial success but a long 
term effectiveness in insulin production failed. 
Various mechanical insulin infusion ^ apparatuses have 
been part ial ly successful but s t i l l fall short of providing the 
activity of a functioning pancreas. It is a subcutaneous device 
which is implanted in the peritoneum or thigh. It has got a 
system of estimating blood sugar throughout a 24 h r s . period with 
a canula inserted into the vein, a glucometer for measuring blood 
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sugar and an automatic computer. Depending on the blood sugar 
the insulin is delivered throughout the 24 h r s . period. However 
there are certain disadvantages of th is therapy for example r isk 
of infection, mechanical failure, unexplained hyperkalemia and 
sudden death. 
A portable insulin - Infusion pump has been used 
experimentally on diabetic patients, but th is device i s cumbersome 
in i t s current stage of development and has had problems with 
battery failure, short circuit and syringe holder displacement. 
Much hope is held for successfully transplanting 
pancreatic tissue or developing an effective device for insulin-
infusion control of blood sugar. Basic to this research is the 
assumption that long-term control of blood glucose levels will 
prevent the pathological processes and complications of 
diabetes. 
Another area of research that Is arousing much 
interest i s focussed on programming the Escherischia coU. to 
menufacture insulin. Diabetics now depend on insulin taken from 
the pancreas of animals; should there be a serious interruption 
in the major drug companies production of insulin, i t is estimated 
that the supply on hand would last only 6 months. This new 
technique for producing Insulin i s s t i l l In the experimental stage 
and very costly, but the possibi l i ty of i t s successful development 
is encouraging. 
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I ( i) Rationale of Employing Animal Model : 
The genetics of diabetes i s extraordinarily complex, 
inheritance i s polygenic, exhibi ts var iable penetrance and is 
susceptible, to environmental influence. In human populations, 
these factors are difficult to study and impossible to control. 
Family his tor ies tend to be inaccurate and include only a few 
generations. People marry and remarry; most couples have a few 
children, families move and break up. Hence the use of animals 
rather than human subjects may, to some extent, overcome these 
difficulties. The animal colony permits clarification of the genetics 
of some forms of diabetes. Accurate geneologies can be 
maintained and many generations studied in a relat ively short 
period of time. The knowledge that a certain percentage of 
animals will rel iably develop diabetes becomes a powerful tool 
in the study of preventive therapies for the disease. The animal 
colony also permits study of interaction of heredity and 
environmental factors such as diet , drugs, toxins and infectious 
agents. 
Diabetes may occur acutely but i t is also a chronic 
disease with late vascular sequlae. Understanding it fully, will 
require, metabolic, histoloigic and immunologic studies at many 
stages of i l lness . No diabetic patient, however, can provide such 
extensive material, particularly at the time of onset when li t 
would be of paramount interest . The anatomic location of the 
pancreas i s an obvious problem for researchers . The lifespan 
of the human is another problem, i t is difficult to study the 
natural history of diabetes in subjects who might outlive the 
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investigator. 
Lastly, there are ethical impediments to the study 
of human diabetes. Provocation of the disease is obviously not 
permissible in humans, but constitutes a fruitful line of animal 
research. As a corollary, ' new therapeutics to prevent or reverse 
the disease must first be tested in animals. 
Limitations of the use of Animal Model : The advantages of animal 
models are ofcourse balanced by limitations. No animal model 
of diabetes corresponds perfectly to human diabetes. The 
pathophysiology of most animal diabetic syndrome is poorly 
understood and difficult to relate to human data. The clinical 
course of animals with these syndromes may be variable and 
unpredictable. The vascular sequlae of animal diabetes syndrome 
have also proven difficult to s tudy. Nonetheless, much of our 
hope for future progress in diabetes research s t i l l res t s with 
animals. 
Spontaneous hyperglcemic syndromes have long been 
recognized in mammalian species . Leblanc (1861) documented the 
occurence of diabetes in animals. Diabetic cats (Gepts and 
Toussalnt, 1967), tree shrews (Rabb et a l . , 1966) and ground 
squirrels (Stuhlmanet a l . , 1977) have been found, as have diabetic 
pigs, horses, apes, sheep and goats (Cameron et a l . , 1972). 
Isolated cases of diabetes have been reported in a fox (Fox, 
1923) a dolphin (Cameron et a l . , 1972) antelopes (Vander Gaag 
et a l . , 1973) and a hippopotamus (Cameron et a l . , 1972). While 
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these observations proves the phylogenetic extuberance of 
diabetes, the same limitations which impede the study of the 
disease in humans apply to most of these species as well . The 
data gathered from the larger animals are Inconsistent as to be 
of limited value. 
From the standpoint of efficiency and cost, the small 
laboratory rodent i s the most satisfactory animal in which to 
study diabetes. Not only do several species become spontaneously 
hyperglycemic, but some are amenable as well to the experimental 
Induction of diabetes. Costs are reasonable, generation time short 
and l i t ter large. In addition, the genetics and environment of 
such animals are controllable. 
I (j) Chemical Agents Capable of Inducing Diabetes : 
The use of chemical agents to produce diabetes permits 
detailed study of the biochemical,hormonal and morphologic events 
that occur during and after the induction of a diabetic s ta te . 
The two agents that have been most extensively studied 
and have yielded the vast majority of information pertinent to 
human diabetes are alloxan and streptozotocin. Both are beta 
c^totoxins which in diabetogenic doses are relat ively free of 
nonspecific toxic effects and effectiveness of these diabetogenic 
chemical agents is highly dependent on the age, sex and species 
of the recepient. In contrast to most other chemical agents 
capable of inducing? diabetes, there i s a wide margin of safety 
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with these two compounds. The effective diabetogenic dose( ED ) is 
4-5 times lower than the lethal dose {LD-_) and both sexes are sus-
ceptible . In most animals the toxicity of both compounds seems 
specific for the p -ce l l exclusively. 
(i) Alloxan : 
Alloxan was first rioted to have diabetogenic activity 
by Dunn in the course of studies on the effect of uric acid 
derivatives on kidney following trauma (Dunn et a l . , 1943). Its 
mechanisms of action is not known. Available evidence indicates 
that the in i t ia l effect of alloxan i s mediated through some form 
of membrane interaction on the surface of beta cel l . 
14 Autoradiographic studies using C alloxan reveal a high affinity 
on the drug for is let cell membrane (Landau and Renold, 1954). 
(ii) Streptozotocin (StZ) : 
Streptozotocln, an N-nitrosoderivative of D-glucosamine 
was init ial ly isolated from cultures of Streptomyces achromogens, 
but subsequently has been synthesized in the laboratory (Herr 
et a l . , 1959-60). Like alloxan, streptozotocin is a relatively 
selective beta cytotoxin in certain animal species, causing an 
initial t r iphasic glucose response and then permanent diabetes. 
Cell membrane binding is again the likely first step in the 
pathologic process. In case of streptozotocin, the alpha anomer 
of the glucosamine moiety has been shown to render the compound 
more cytotoxic than the beta anomer, suggesting that the drug';s 
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toxicity is mediated through specific recognition by some receptor 
on the beta cel l (Rossini et a l . , 1977). It has further been 
suggested that the glucose component of streptozotocin enhances 
i t s uptake into the beta cell whore the cytotoxicity of nitrosourea 
moiety can be concentrated (Schein and Loftuss, 1968; Gunnarson 
et a l . , 1974; Wilander and Gunnarson, 1975). Removal of the 
glucose moiety renders the compound much less specifically toxic 
for beta cel ls (DuUii and Soret 1977); substitution of galactose 
for glucose also decreases i t s effectiveness (Fischer and Ricker, 
1975). 
Circulatory half life of streptozotocin is 15 minutes, 
whereas for alloxan i t is 1 minute. Fasting has l i t t le effect on 
diabetogenic activi ty of streptozotocin. The most effective route 
of administration of streptozotocin is intravenous as well as 
intraperitoneal v/hereas alloxan can be administered most 
effectively intravenously. 
Within the beta cel l streptozotocin is believed to 
reduce levels of nicotine adenine dinucleotide (NAD) by both 
decreasing i ts synthesis and increasing i t s breakdown (Gunnarson 
et a l . , 1974). Nicotinamide protects animals against the 
cytotoxicity of both streptozotocin and alloxan. 
Histopatholrjgically, beta cel l necrosis without insulit is is 
routinely observed. (Dulln and Soret, 1977; Ganda et a l . , 1976). 
As is the case with alloxan, certain carbohydrates have the 
ability to protect the beta cell against streptozotocin, but among 
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them only 3-0-methylglucose protects equally well against both 
(Ganda at a l . , 1976). 
I (k) Objectives of the present study : 
A perusal of the literature reveals a great diversi ty 
in the dosages of the streptozotocin required to Induce diabetes 
in the experimaital animals. Therefore the first task for anybody 
to create an animal model i s to precisely work out the 
appropriate doses of StZ which may bring about a discernible 
yet not fatal alteration in various histophysiological parameters 
commonly employed to judge the induction of diabetes. Further 
it was also of interest to evaluate the efficacy of the 
administration of single dose of StZ versus that of multiple doses. 
Hardly any data is available to show if the dose of StZ causing 
hyperglycemia is also effective in producing pathological changes 
in the susceptible target organs such as pancreas and kidney. 
It must be mentioned that th is basic study constitutes an 
important aspects before attempting management strategies with 
regard to prevention of th is disease. 
The present study, therefore, envisages the following 
aspects : 
(1) To establish the base line data of various parameters 
such as blood glucose, glycosylated hemoglobin (HbA.c), 
plasma insulin, lipid profile, plasma osmolarity and 
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histological features in the pancreas and kidney in 
the normal albino ra ts of both sexes. 
( i l) To work out the relat ive efficacy of single and 
multiple doses of StZ as Judged by the changes in 
the above mentioned blood parameters as well as 
histological alterations in the p&ncreas and kidney. 
( i l l ) To evaJuate If the effective doses show some sex 
dependent variations. 
11. MATERIALS AND METHODS 
A: Care and Maintenance of Animals : 
Adult male and female albino rats weighing about 150-
200g were obtained from the Central Animal House, J .N. Medical 
College, Allgarh and were maintained In the animal house of 
Zoology department under controlled photoperlod regimen of 12 
hrs of light (08:00 to 20:00 hr) alternating with 12 hr of 
darkness (20:00 to 08:00 h r ) . They were fed aid libitum everyday 
with pelleted Hlndlever laboratory animal feed (Hindustan Lever 
Limited, Delhi, India) and were given free excess to water. 
B: Streptozotocin : 
Streptozotocin (Lot No. 37F-0112, mixed anomers) 
was purchased from Sigma Chemical Company (St. Louis, U.S.A.) . 
The appropriate dosages were freshly dissolved in 0.1 M citrate 
buffer (pH = 4.5) and injected intraperltoneally within 15 min. 
of dissolution in a vehicle volume of 0.4 ml with 1-ml of 
Tuberculin syringe fitted with 2 4 gauge needle. 
C: Experimental Protocol : 
Two sets of experiments were conducted on 
well-acclimated ra ts maintained under controlled laboratory 
conditions as described ear l ier . 
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(i) SET A 
In this set, well - acclimated rats were divided into 
two experimaital groups. 
Experimental Groups : 
Group-I : Consisted of 11 ra ts (6 male and 5 female) and were 
injected with only ci trate buffer (pH = 4.5) to serve 
as control. 
Group-II: Consisted of 8 ra ts (4 male and 4 female) and were 
given two intraperitoneal injections of streptozotocin 
(40 and 15 mg/kg body weight on day 1 and 2 
respectively) dissolved in ci t rate buffer. No 
treatment was given on day 3. 
Sampling Protocol : 
On day 4 i . e . after 48 hrs of the last injection, blood 
samples from both control as well as experimental groups were 
collected by cardiac puncture with the help of 5-ml glass van 
syringes fitted with 24 gauge needles. The blood was soon 
transferred into tightly stoppered heparinized v ia l s . Blood 
samples were centrifuged at 3,000 r . p . m . on a Remi Centrifuge 
(Reml, India, model R 24) for 15 min. and plasma was separated 
for analysis of glucose and the red blood cells for glycosylated 
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hemoglobin (HbA %). 
•\_c 
Estimations 
(1) Plasma Glucose : 
Plasma glucose was assayed by the Glucose-O-toludine 
method. In a 0.1 ml of plasma sample contained in stoppered 
test tubes, 3 ml of 0-toludine reagent (1.5 gm of thiourea in 
940 ml of glacial acetic acid, with the subsequent addition of 
60 ml of 0-toludine when completely dissolved) was added in each 
tube. All the tubes were incubated at lOO'iiC in a water bath 
for 12 min. After cooling these tubes, the absorbance was 
measured on 630 nm against reagent blank and values were 
expressed in mgSfe. ; / / / 
( 2 ) Glycosylated Hemoglobin (HbA.^,*) : 
HbA,c% was measured by the method of Fluckigger 
and Winterhalter (1976). The main steps of estimation are as 
follows : 
After the separation of plasma, 1 ml of R.B.Cs were 
transferred to a fresh tube. They were washed with 2 ml of 
0.9% sodium chloride thrice and after final wash, the packed 
R.B.Cs were mixed with 1.4 ml of double dist i l led water and 
0.4 ml of 0.1% glucose; shaken vigorously and centrifuged for 
10 min. to se t t le the deb r i s . Hemoglobin concentration of the 
- se -
ll emoly sate was determined lay Drabkin solution and concentration 
adjusted to 10%. In 2 ml of this hemolysate used for estimating 
the glycosylated hemoglobin, 1 ml of oxalic acid (O.IM) was 
added. The mixture was digested at 100°C in a boiling water 
bath for 90 min. and then cooled to room temperature. Later on,1 ™1 
of 40% TCA (Trichloroacetic acid) was added and mixed thoroughly 
with a glass rod and centrifuged for 7 min., out of this 2 ml of 
clean supernatant was transferred to a fresh tube and 0.5 ml of 
0.05 M thiobarbituric acid was added, mixed and kept at 45°C 
for 30 min in water bath . The released 5-H.M.F. (5 Hydroxy 
methyl furfural) was measured at 443 nm against the reagent 
blank. The absorbance of 10 gm/litre concentration of HbA^c corres-
ponds to 0.06 at 443 nm. The relative percent of hemoglobin 
glycosylated was accordingly calculated. 
(ii) SET B 
This set was designed to evaluate the relative 
diabetogenic efficacy of single versus multiple doses of 
streptozotocin. In this set , well accUmated rats maintained under 
controlled conditions as described previously were divided into 
three groups. 
Experimental Groups : 
Group-I : Consisted of 6 rats (3 male and 3 female) which were 
injected Intraperitoneally with 0.4 ml ci t rate buffer 
(pH = 4.5) to serve as control. 
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Group -II : Consisted of 4 ra ts (3 male and 1 female) which 
were given a single intraperitoneal injection of StZ 
til the dose of 45 mg/k"g b .wt . for just one day in 
a vehicle volume of 0.4 ml ci t rate buffer. 
Group-Ill : Consisted of 6 ra ts (3 male and 3 female) which 
were given intraperitoneal injections of StZ in 
multiple sub diabetogenic doses of 40, 10, 5 and 5 
mg per kg body weight on day 1, 2, 3, and 4 
respectively in a vehicle volume of 0.4 ml of citrate 
buffer. 
Sampling Protocol : 
On day 5 i . e . 24 hrs after the last injection of StZ, 
the blood was collected from the animals of the three groups 
I, II and HI by cardiac puncture with the help of 5-ml 
heparinized glass van syringes fitted with 24 gauge needles. 
The blood was soon transferred into heparinized vials and 
centrifuged at 3,000 r . p . m . for 15 min on a Remi centrifuge 
(Model R 24) to separate plasma for estimation of glucose, 
cholesterol, insulin and osmolarlty. The R.B.Cs were utilized 
for the estimation of glycosylated hemoglobin (HbA. ) . 
The kidney and pancreas of the animals from al l the 
three groups were fixed in 10% buffered neutral formaUn for 24 
hrs and were processed subsequently to obtain five micron thin 
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paraffin sections which were stained with hemotoxyllne and eosin 
for histological observations. 
Estimations : 
(1) Plasma Glucose And Glycosylated Hemoglobin (HbA^^%) : 
Plasma glucose and HbA^^ were measured by 'Glucose-
0-toludine' and Fluckigger and Winterhalter (1976) methods 
respectively as detailed in set A. 
( 2 ) Plasma Cholesterol : 
Cholesterol in plasma was extracted by acetic 
anhydride in the presence of acetic acid according to the method 
of Carrand Drekter (1956). 
An aliquot of 0.2 ml of plasma was taken in a l l tubes 
except reagent blank in which 0.2 ml of dis t i l led water was 
taken, then 0.8 ml of glacial acetic acid and 4 ml of acetic 
anhydride was added in each tube without touching the wall of 
the tube. It was mixed by gentle rotation, centrifuged and 
supernatant was decanted into clean tubes in which 1 drop of 
dehydrating agent was added. 
After th is a l l the tubes were rotated to mix the 
contents. If the solution does not become hot within 1-2 mln, 1 
more drop of dehydrating agent was added and mixed immediately 
and finally the tubes were placed in water bath maintained at 
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25°C. After 5-10 mln when the tubes have cooled to 25°C, 1 
ml of acid reagent was added to the reagent blank tube, mixed 
well and replaced in the water bath at 25°C for 20 min, 1 ml 
of acid reagent was added to other tubes also at 1 min interval 
and kept in the water bath at 25°C for 20 min. The absorbance 
was read against the reagent blank at 630 nm or with a red filter 
in colorimeter (Systronics 101). 
The tubes were read at 1 min interval following the 
same order as observed for addition of acid reagent. Plasma 
cholesterol concentratation was expressed as mg%. 
(3 ) Plasma Insulin : 
Insulin levels in plasma were measured by 
Radioimmunoassay (RIA) employing Insulin Radioimmunoassay kit 
(code RIAK-1) obtained from Isopharm, Radiopharmaceuticals 
Division, Bhabha Atomic Research Centre, Turbhe Complex, New 
Bombay which measures insulin in a range of 0-200 micro unit/ml. 
Working Procedure : Reagents supplied in lyophilised form are 
under vaccum sealing and were decapped carefully so as to avoid 
spilling of contents. Rubber closures were not interchanged and 
specified, volume of buffer was added as per suppl ie r ' s protocol. 
It was allowed to stand at room temperature for five min and 
then mixed gently to avoid foaming. Reconstituted reagents were 
stored below -5°C and are stable upto one week. Polyethylene 
glycol (PEG) and buffer solutions were stored at 4°C. 
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Reconstitution of Kit Reagents 4 
1. Insulin Standard (lyophilised) : Added 5 ml assay buffer 
and mixed gently. The insulin concentration in the reconstituted 
standard is 200 micro unit/ml, 5 more standards were prepared 
as indicated in table below and mixed gently on a vortex mixer. 
TABLE 
Standard A (ml) 
Assay Buffer (ml) 
Insul in Concentration 
(;iU/ml) 
1.0 
1.0 
100.0 
B 
0.5 
1.5 
50.0 
C 
0.5 
3.5 
25.0 
D 
0.5 
7.5 
12.5 
E 
0.3 
7.7 
7.5 
F 
2. Anti-insulin Serum (lyophilised) : ( Raised in guinea pig 
against porcine insulin). Added 10 ml assay buffer and mixed 
gently on a vortex mixer. 
3. Insulin free Serum (lyophil ised) : Added 2 ml double 
dis t i l led water and mixed gently on a vortex mixer. 
125 4- I Radioiodinated Insulin : Added 6 ml assay buffer and 
mixed gently on a vortex mixer. 
5. Second Antibody : Added 10 ml assay buffer and mixed 
gently. 
MODE:EVALUATE: STD,CURVE 
0. 10. 20. 
1—I—f I I t I I 
50 . 100. 
X-AXIS 
Cone ] L I N / L O G 
Sca le ' 
Y -AX IS 
r e s p : S /BO 
Scale '• 
FITTING ALGORITHM 
SPLINE 
Cone : LOG 
resp : 8 / 8 0 
ITERATI0NS = 2 
2 0 0 . 
Insulin concentration j ju / ml 
STANDARD CURVE FOR INSULIN RIA 
Fig.1 
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6. Control Serum (A 6 B) : Added 0.5 ml double dist i l led water 
and mixed gently. 
All the standards and samples were set in duplicate. 
Tubes numbered upto 18 were set for the standard curve and 19 
onwards in duplicate for each sample. Assay buffer, standards, 
insulin free serum, antiinsuHn serum and samples to the tubes 
were added as per flow sheet supplied with the k i t . They were 
mixed gently on a vortex mixer, covered with an aluminium foil 
and incubated in a refrigerator at 2 to 4°C overnight or 
alternatively at room temperature for 2 h r s . After th i s , 0.1 
125 
ml of radioiodinated I-insulin was added to a l l the tubes, 
mixed gently on a vortex mixer and incubated in refrigerator at 
2 to 4°C for 5 h r s or alternatively at room temperature for 3 
h r s . , 0.1 ml second antibody was added to all the tubes except 
1 and 2 followed by the addition of 1 ml of PEG to al l the tubes 
except 1 and 2. The contents were mixed thoroughly. These 
tubes were incubated at room temperature for 20 min. All the 
tubes except 1 and 2 were centrifuged at 1500 g for 20 min on 
a Refrigerated Centrifuge (Model Sorrvoll RT 6000B). 
After centrifugation, supernatant was discarded and 
precipi tate was counted in a mini gamma counter (LKB WALLAC, 
model 1275). On the basis of B/BO and known concentration a best 
fit standard curve (see Fig. 1) was drawn and the concentration 
of unknown were calculated with the help of this standard curve 
and values expressed as lUi/ml. 
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(4) Plasma Osmolarlty : Plasma osmolarlty was determined by 
vapour pressure osmometer (Woscor, Inc 459 South Main Street, 
Logan Utah, USA Model 5500), The instrument was initially 
calibrated with two 100 and 1000 mOsm known standards. Only 
10 ^ 1 of sample volume was required for determination of 
osmolarlty which was displayed directly as mOsm/kg. 
Histological Studies : 
For light microscopic studies, 5 micron thin 
hemotoxyUne-eosin stained sections of kidney and pancreas WBBB 
observed under Leltz microscope (Model HG1500, Mlcroworld) and 
photomicrography was done with the help of bu i l t - in camera 
attachment. 
For morphometrlc analysis, the* diameter of the nuclei 
of fifty cells of pancreatic is lets in a randomized pattern was 
measured in a l l the three groups with the help of Occular-
micrometer fitted in the eye-piece of the microscope. From the 
diameter of these nuclei, the radii were obtained and nuclear 
2 
area was calculated by employing TT r" formula. 
D: s ta t i s t ica l Analysis : 
Data for a l l parameters were expressed as mean ± 
standard er ror . Statist ical comparisons between experimental and 
control groups were made by Student ' t ' test (Snedecor and 
Cochran, 1971). 
TABLE-1: Plasma glucose and g lycosy la ted hemoglobin in a lbino 
r a t s following t reatment with s t rep tozoc in (StZ) 
inject ions (40 and 15 mg/kg b . w t . / d a y on 1 and 2 day 
r e s p e c t i v e l y ) . Group injected with c i t r a t e buffer 
se rved as cont ro l . 
SI . No. CONTROL 
Ci t ra te buffer injected 
EXPERIMENTAL 
StZ-lnjected 
1 . Plasma glucose 
(mg%) 
63.7±6.8 
(11) 
230.4+11.7' 
(8) 
2. Glycosyla ted 
hemoglobin 
(HbA^^%) 
4.67±0.43 
(11) 
5.90±0.37 
(8) 
Note: 1. Resul ts e x p r e s s e d as mean ±S.E.M.; p 0 .001 ; 
b 
p 0.05 
2 . F igures in pa ren theses i nd i ca t e number of animals in 
each g roup . 
300 
250 
200 
150-
100-
50 
( ) No. OF ANIMALS 
MEANiSE: 
S Z: Streptozotocm 
DOSES A0,15,Tng/l<g b.wt./day for Z days 
(11) 
(8) 
T 
(8) 
01) 
0 
CONTROL SZ-treated gp. CONTROL SZ-treated gp. 
(Buffer injected ) (Buffer in/ected) 
Fig.2 
TABLE-2 : Plasma glucose and glycosylated hemoglobin values 
in male and female albino ra ts following two injections 
of streptozocin (StZ) at the dose of 40 and 15 mg/kg 
b .wt /day on day 1 and 2 respect ively. Citrate buffer 
injected group served as control. 
SI.No. 
1. Plasma glucose 
2 . Glycosylated 
hemoglobin 
HbA^^% 
Control 
Buffer- injected 
63.70±6.80 
(11) 
4.67±0.43 
(11) 
S tZ- t rea ted 
Male 
223.95±21.18 
(4) 
5.65+0.44 
(4) 
group 
Female 
237.15112.35^' 
(4) 
6.3±0.60 
(4) 
Note: 1. Values expressed as mean ± standard error of mean. 
2. NS: Not significant, when comparisons made between 
male and female rats with buffer injected control. 
3. Figures in parentheses indicate the number of animals 
in each group. 
i n . OBSERVATIONS 
(i) SET A 
Changes in plasma glucose and glycosylated hemoglobin following 
two Injections on consecutive days of the StZ at the dose of 40 
and 15 mg/kg b»wt./day In male and female albino rats : 
A perusal of Table 1 and Fig. 2 clearly reveals that 
the StZ injections at the dose of 40 and 15 mg/kg b .wt /day on 
day 1 and 2 respectively and sacrificed on fourth day bring about 
a significant diabetogenic response in the albino r a t s . Plasma 
glucose levels show a nearly four fold increase in the StZ treated 
groups compared to those of the buffer Injected control (cf.63 
vs . 230 mg% in control vs StZ treated group). These values 
are s ta t is t ical ly highly significant (P < 0.001). Glycosylated 
hemoglobin (HbA^ %) also show a s tat is t ical ly significant increase 
(P < 0.05), though the overall magnitude of the change in this 
parameter is not as dramatic as those of glucose values (4.67 
vs 5.9% in control and StZ treated group respect ive ly) . It is 
also evident from the data that there is no sex related changes 
in the diabetogenic response following StZ treatment as Is evident 
from no s ta t i s t ica l significance in the blood glucose and 
glycosylated hemoglobin between male and female ra ts (Table 2) . 
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( l i ) SET B 
Changes in plasma glucose, cholesterol. Insulin, osmolarlty and 
glycosylated hemoglobin following treatment with a single shot 
(45 mg/kg b;wt.) and multiple doses (40, 10. 5 and 5 mg/kg 
b.wt/day on day 1,2,3 and 4 respectively) of streptozocin (StZ) 
In albino rats : 
In th is experimental set , changes in various 
physiological parameters in a l l the three groups of animals are 
summarized in Table 3 and Figures 3-7. 
(1) Plasma Glucose : 
It is evident from Table 3 and Fig.3 that streptozotocin 
(StZ) administration following either a single or multiple dose 
treatment causes significant diabetogenic response in the albino 
r a t s . However, regarding relative efficacy of both the treatments, 
singe dose appears to be much more effective as indicated by 
nearly 5-fold increase in plasma glucose levels (380.8 v s . 61.5 
rag% in treated and control groups respect ively as compared to 
4J5-fold increase in multiple dose treatment (284 vs 61.5 mg% in 
treated and control groups respect ive ly) . Hence, If Increase in 
plasma glucose level is to be the only Indice, then single dose 
treatment of 45 mg/kg b .wt with StZ has proved highly effective 
in causing diabetogenic response in th is s t rain of albino ra t s . 
( ) No. OF ANIMALS 
r n MEANt S.E.^ 
SZ : Streptozotocin 
TMULTIPLE A0,10,5&5 mg/kg b.wt./day for A days 
[DOSES ' 
rSINGLE A5 mg/kg b.wt. 
LOOSE 
oL 
(6) 
I 
CONTROL 
(Buffer injected) 
(6) 
I 
MULTIPLE 
DOSE* I 
(M 
I 
SINGLE 
DOSE 
SZ-treated gp. 
Fig. 5 
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(2) Glycosylated hemoRlobin : 
The surprising outcome of this experiment i s a highly 
significant elevation in glycosylated hemoglobin concentration 
following treatmait with StZ (see table 3 and Fig .4) . However the 
re la t ive efficacy of both the types of treatment (single v s . 
multiple dose) show just the opposite response pattern compared 
to the plasma glucose. Here, multiple dose treatment appears 
to be much more effective (cf.12.7% in StZ group with 6.5% in 
control) (P< 0.01) as compared to single shot In which the HbA 
levels r ise only upto 11.5% from the ci trate buffer injected control 
(6.5%). Interestingly, there may even be a stat ist ical ly 
significant difference in the absolute values of single vs multiple 
dose treated group. 
(3) Plasma cholesterol : 
StZ administration in albino ra ts brings about a 
significant increase in plasma cholesterol level (see Table 3 and 
Fig. 5) . The pattern of response in single versus multiple dose 
groups seems to be the same as observed in glycosylated 
hemoglobin i . e . multiple dose treatment of StZ shows a more 
pronounced increase (cf. 122 vs 96 mg% in StZ-treated and buffer 
injected control respectively) as compared to single dose 
administration In which cholesterol increases from 96 mg% in the 
control to 111 [ng% in StZ treated group. It may however be 
noted that quantum of increase in cholesterol level is not as 
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greatly significant as observed either in blood glucose or 
glycosylated hemoglobin. Further, the relat ive increase between 
the two StZ treated groups may not be s tat is t ical ly significant 
(see Fig. 5) . 
(4) Plasma Insulin : 
The changes in plasma insulin levels following StZ 
treatment are depicted in Table 3 and Fig. 6. It is quite clearly 
evident from this data that multiple dose regimen of StZ-treatment 
brings about much greater decUne in the plasma insuUn levels 
as compared to single dose (cf. 11 and 13 JlU/ml of plasma insulin 
levels in multiple and single shot treatment respectively compared 
to 15 ;iU/ml in the buffer injected control) . However, this 
decrease in both the treated groups is not s tat is t ical ly significant 
as compared to buffer injected control. Such a marginal decrease 
in the insulin levels despite highly significant diabetogenic 
response observed on the basis of elevated blood glucose and 
glycosylated hemoglobin is surprising. 
(5) Plasma Osmolarity : 
Perusal of Table 3 and Fig. 7 clearly shows that StZ-
treatment does not seem to have any effect on the plasma 
osmolarity of the rats ei ther in single or multiple dose treatment 
in the presently followed protocol. Interestingly, even the 
average plasma osmolarity values in a l l the three groups are 
- 4 7 -
remarkably close to each other (cf. 302, 302 and 301 in buffer 
Injected, StZ-single and multiple dose treatment respectively) with 
very small standard deviation, thus indicating that the animals 
maintain thei r plasma osmotic pressure in a ra ther restr icted 
range. 
Histological Studies : 
Light microscopic studies of pancreas and kidney were 
carried out on buffer injected control (group I) and StZ-treated 
group with single dose (45 mg/kg b.wt; group II) and multiple 
doses (40, 10, 5 and 5 mg/kg b.wt/day on day 1,2,3, and 4 
respectively; group I I I ) . The results are depicted in figures 
8-21, for pancreas and figures 22-27 for kidney. Further, in 
order to quantify the extent of changes in is let cells , the nuclear 
areas of both control and StZ-treated group were measured which 
have been presented in Table 4. 
The is lets in the control rats : 
The i s le t s of Langerhans are unevenly scattered in 
the pancreatic tissue and they are often quite abundantly 
distributed and are of varying sizes in the same lobule of 
pancreas (see Fig. 8 ) . Each islet is separated from the acini 
by a reticular membrane and is let is arranged in anastomosing 
cellular plates or cords. Is le t cells appear comparatively paler 
than the surrounding acinar cells in hemotoxylin and eosin staining 
(see Fig. 8 and 9 ) . 
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In the control group, well delineated is le ts are 
completely enmeshed in the surrounding acinar cells of the 
exocrine panci-e^s. The is le t cells are compactly arranged, with 
negligible intercellular space and no inflammatory cells are 
observed (see Fig. 10 and 12). 
Changes following StZ-treatment : 
Pancreatic is le ts of group II rats sacrificed after 4 
days of single intraperitoneal injection of StZ reveal significant 
architectural d isar ray which also extends into surrounding 
exocrine tissue (cf. Fig. 10 and 11). Further, StZ-treatment also 
seem to bring about an increase in intercellular space compared 
to control rats (cf. Fig. 10 and 11). Another significant change 
following StZ-treatment i s the occurrence of per ipheral widening 
between pancreatic acinar (exocrine tissue) and islet cel ls , (see 
Fig. 10 and 11) . These changes are more clearly discernible 
under higher magnification (cf. Fig. 12, 13, 14 and 15). 
Pancreatic i s le ts of group III ra ts injected with 
multiple doses of StZ also show architectural disarray but to a 
lesser extent as compared to single dose StZ-treatment. Further, 
eventhough the per iphera l widening between acinar and i s l e t cells 
does exist but i t is not as prominent as in the animals with 
single dose of StZ-ti'eatment (see Fig. 16 and 17). 
Morphometric measurements of nuclear area of islet 
cells in control as well as StZ-treated group have shown a 
TADLE-4 : Changes In the nuclear area of pancreatic is let cells of 
albino rats following treatmoit with a single (45 mg/kg 
b.wt) and multiple doses (40,10,5 and 5 mg/kg b.wt) 
on day 1,2,3 and 4 days respectively) treatment with 
Streptozotocln (StZ) 
2 
Nuclear Area (iim ) 
Control StZ-treated group Stat ist ical Buffer injected Single dose Multiiple dose Analvsis 
35.46 ± 3.22^ 23.24 ± 1.43 22.80 ± 1.49 p < 0 . 0 0 l ^ a 
(50) (50) (50) p < 0.001^ 
Note : a. Mean ± S.E. of Mean, Figures In parentheses indicate 
number of cells counted. 
bac. Level of significance of single dose and multiple dose 
of StZ-treatment compared with buffer injected control. 
- 4 9 -
signlflcant reduction in nuclear area of is let cells of rats following 
StZ-treatment (see Table 4 and Figs. 18 and 19). The mean 
2 
nuclear area of is let cells of control rat i s 35.46 ;im which gets 
2 
reduced to 23.24 and 22.80 ;i,ra in ra ts following StZ-treatment 
with single and multiple doses respect ively. It is also apparent 
that the extent of reduction in the nuclear area caused by StZ-
treatment ill both single as well as multiple dose groups i s more 
or less of the same magnitude since there is no stat ist ical ly 
significant difference In the mean nuclear area of both these 
groups (see Fig. 20 and 21 and Table 4 ) . 
In the present study, insulltis or inflammation in islet 
cells, if any, could not be observed in hemotoxylin and eosin 
stained sect ims of pancreas following StZ-treatment with ei ther 
single or multiple doses. 
In this experimental set (Set B) , histological changes 
in pancreatic is le ts of rats injected with a single dose of StZ-
are much more pronounced as compared to those of multiple dose 
Injected ra t s which correlates well with the changes in plasma 
glucose levels in respective groups (5-fold vs S^s-fold increases 
in plasma glucose levels in single v s . multiple StZ dose (see Fig. 
3 and Table 3) . 
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Light microscopic studies of kidney tubules : 
These studies were carried out in the same way as 
described previously for pancreatic i s l e t s . The observations are 
presented in the Figures 22-27. 
Kidney tubules of normal rat : 
Tho histological preparations of kidney from buffer 
injected control show that the various segments of kidney tubules 
are well preserved. Abundant glomeruli, portion of nephron 
segment with interspersed blood capil laries can also be clearly 
seen (Figs. 22 and 24). 
Kidney tubules of StZ-treated rats : 
A close examination of Figures 23, 25, 26 and 27 
reveal that there i s no significant histological alteration in the 
glomeruli or any other segment of kidney tubule following 
StZ-treatment e i ther with a single or multiple dose under the 
present experimental protocol. 
All the constituent structures of kidney tubule in StZ-
treated group appear to be well maintained with no indication 
of hyaline deposition or increase in messangial thickening (see 
Fig. 24 and 25). No difference was found in the structure of 
glomerulus of the ra ts injected with single and multiple doses 
of StZ respectively (see Fig. 26 and 27). 
Photomicrographs of pancreatic islets from ci trate buffer injected 
(control) albino rats (Hemotoxylin and eosin). 
Fig. 8 Note the abundance of is le ts (3 is le ts indicated by 
arrows are seen in photograph as whitish patches) in 
the pancreatic tissue (X 50). 
Fig. 9 Acinar and islet components are clearly distinguishable 
from one another; i s le t is paler than the (Indicated 
by arrow) surrounding acinar cells and intercellular 
space is negligible (X 100), 
Fig. 8 
Fig. 9 
Photomicrographs of pancreatic islets from control and Stz-treated 
albino ra t s , (Hemotoxylin and eosin X 250). 
Fig. 10 The well delineated is lets of a normal rat are enmeshed 
in the surrounding acinar cells of the exocrine 
pancreas. 
Fig. 11 A significant architectural d isarray is clearly vis ible 
following a single dose StZ-treatmait in albino ra t s . 
Note the distinct per ipheral gap (shown by arrow] 
between the pancreatic is let and the acinar cel ls . 
Fig. 10 
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Fig. 11 
Photomicrographs of the magnified view of pancreatic is lets from 
control (Buffer Injected) and StZ-treated r a t s . (Hemotoxylin and 
eosln X 400). 
Fig. 12 Pancreatic islet from the control ra t . No gap between 
the Islets and surrounding acinar cells and no 
indication of any architectural d i sa r ray . 
Fig. 13 Pancreatic Islets from a single dose streptozotocin 
treated r a t . Note a distinct per iphera l disarray around 
the i s l e t . The gaps [indicated by arrows) between 
the Islets and the acinar cells and within the islets 
itself are also noticeable. 
* » 
A • r ' 
Fig.12 
Fig.13 
Photomicrographs of a highly magnified view under oil immersion 
of the pancreatic islets from the ra ts treated with single dose 
of StZ. (Hemotoxylin and eosin X 1000). 
Fig. 14 Note a further highly magnified view of architectural 
d isar ray within i s le t cells as shown by arrows. 
Fig . 15 Note prominent gap between is le t and acinar cells 
(shown by arrows) as vis ible under oil immersion. 
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Fig.U 
Fig.15 
Photomicrographs of pancreatic islets of rat injected with single 
and multiple doses of streptozotocin (Hemotoxylin and eosin X 400J. 
Fig. 16 Is le t from the single dose StZ-treated ra t showing a 
dist inct gap between islet and surrounding acinar cells 
(shown by arrow). 
Fig. 17 Note a much less pronounced architectural disarray 
evident from only a marginal gap between the islet and 
the surrounding acinar cells in the multiple StZ-treated 
^ group. 
Fig.16 
Fig. 17 
Photomicrographs of the pancreatic islet cells from buffer injected 
control and streptozotocin treated rats under oil immersion 
(Hemotoxylln and eosln X 1000). 
Fig. 18 Islet cells from buffer injected control ra t s . Note the 
large nucleus and degranulated cytoplasm. 
Fig. 19 Islet cells from single dose StZ-treated r a t . Note a 
dist inctly small nuclear diameter and heavily granulated 
cytoplasm. 
Fig. 18 
•••V# S * . ^ * 
Fig.19 
Photomicrographs of the pancreatic is let cells from single and 
multiple doses StZ-treated r a t s under oi l immersion (Hemotoxylin 
and eosin X 1000). 
Fig. 20 Is le ts from single dose StZ-treated rats showing reduced 
nuclear diameter and densely granulated cytoplasm. 
Fig. 21 Is le ts from multiple dose StZ-treated ra t s . No apparent 
changes are noticed in the nuclear diameter of this 
group as compared to that of the single dose injected 
group shown in Fig. 20. 
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Fig. 20 
Fig-21 
Photomicrographs of renal cortex from buffer injected control as 
well as StZ-treated rats (Hemotoxylin and eosin). 
Fig, 22 Many glomeruli are seen in the kidney tubules of buffer 
injected control r a t . Note well preserved histological 
integrity of glomeruli and various segments of renal 
tubule (X 250). 
Fig. 23 Sections of kidney tubule of single dose StZ-treated 
r a t s . All the histological features appear to be well 
preserved and no apparent histological difference from 
the buffer injected control i s seen (X 400). 
* . ^ - - . V . \'%J'-' ' - ^ ^ s - * - A £••-
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Fig. 22 
i 
Fig. 23 
Photomicrographs of renal cortex as seen under oil immersion from 
buffer injected control and StZ-treated r a t s . 
Fig. 24 A magnified view under oil immersion of the glomerulus 
from buffer injected control r a t . 
Fig. 25 A similarly magnified view under oil immersion of the 
glomerulus of single dose StZ-treated group. Structure of 
glomeruUi i s well preserved without any indication of 
hyaline deposition. 
Fig. 24 
L»V 
Fig. 25 
Photomicrographs of renal cortex under oil immersion from single and 
multiple doses StZ-treated r a t s . 
Fig. 26 Glomerulus magnified under oil immersion from single dose 
StZ-treated r a t s . 
Fig. 27 Glomerulus magnified under oi l Immerslcn from multiple dose 
StZ-treated r a t . No histological difference i s apparent 
whai compared with single dose StZ-treated rat as shown 
in Fig. 26. . . 
. \ " ^. 
Fig. 26 
Fig. 27 
IV. DISCUSSION 
Diabetes, despite Its knowledge from the time 
Immemorial, s t i l l afflicts a substantial global population. Even 
after the considerable advancement in science, the ultimate cause 
of the disease remains unknown. Prevaition is s t i l l an unrealized 
goal and even after the discovery of insulin, a definitive therapy 
i s lacking. As a consequence, diabetes research continues 
intensively. One of the major tools in such research is to create 
the animal model of diabetes to facilitate the better understanding 
of the subject. 
Over the last decade, such animal models have 
contributed significantly towards an extensive accumulation of 
knowledge in th is important area. They offer continuing hope 
for greater understanding of the basic pathologic mechanisms and 
complcations and treatment of this disease. Evsnthough an 
immediate extrapolation of these results on animal models to human 
diabetics may not be feasible, this may s t i l l be considered a 
rewarding line of investigation with considerable future promise. 
It must be appreciated that one of the main 
prerequisi tes of any investigation on animal model of diabetes 
is to work out the precise diabetogenic dose of any chemical 
agent proposed to be used. It should also be taken into account 
whether the dose which i s capable of producing hyperglycemia 
is also causing discernible changes in other parameters presumed 
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to be altered during diabetic manifestations. The literature 
survey alcsig th is line reveals an appalling casualness of most 
of the investigators towards standardizing the optimum dosages 
required for induction of diabetes. The majority of the 
investigators have used an arb i t ra ry dose ranging from 60-100 
mg/kg b .wt . For instances, Hough et a l . (1981) employed 65 
mg^'kg b .wt , on rats and obtained about two-fold increase in blood 
glucose levels. A more or less similar dose range of 55-65 mg/kg 
b . w t . was used by a number of other investigators and they 
achieved nearly 1.5-2 times increase in the level of blood glucose 
(Kigoshi et a l . , 1986; Taylor et a l . , 1987; Bretheron-Watt et a l . , 
1989; Brubaker et a l . , 1989; Flatt et a l . , 1989; Ram Lai et a l . , 
1989; Live et a l . , 1990). Olchovsky et a l . (1990) used even 
higher dose of 100 mg/kg b .wt . of StZ to induce about 2's-fold 
glyoemia in the r a t . <' 
Looking at the uniformity of these dosages, it appears 
that no attempt has been made to see if the glycemic state can 
be achieved even with smaller dose. Obviously, excessive dose 
wil l not only be a wasteful exercise but i t may also cause 
undesirable toxic effects on other physiological systems thus 
leading to often erroneous conclusions. Further, there does not 
seem to be any consensus as to whether a single shot or multiple 
subdiabetogenlc dose should be injected to obtain the optimum 
resul t s . The present study has attempted to fill this existing 
lacuna. With the exception of the report by Cameron et a l . 
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(1989) th i s , to the best of our knowledge, is first report to 
convincingly demonstrate that a dose of 45 mg/kg b .wt . of the 
streptozotocin is enough to produce a highly significant diabetic 
respcmse which it evident from nearly five fold increase in the 
blood glucose level. It is unlikely that the effectiveness of this 
dose will be confined only in the presently investigated albino 
ra t s 
Another significant outcome of the present study is 
the observation that there is no sex-dependent susceptibil i ty in 
the induction of diabetes in this particular s t ra in . The 
hyperglycemic level, therefore, does not show any stat is t ical 
difference between male and" female r a t s . This is in contrast to 
the findings of Rossini et a l . (1978) on mice, where male showed 
greater susceptibili ty to diabetes. 
The data on the relat ive efficacy of single versus 
multiple doses have yield interesting resu l t s . It is quite clear 
from our observations that a single shot of StZ produces more 
marked response in causing - diabetic hyperglycemia. However, 
other parameters such as HbA^ , lipid profile and insulin t i ters 
appear to show much greater response in the multiple dose 
injected group. If blood glucose levels are regarded as more 
conventional indice of diabetic manifestations it may not be 
improper to conclude that single shot administration shows a much 
greater diabetogenic efficacy as compared to multiple doses of 
the StZ. 
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Glycosylatlon of hemoglobin Is a p o s t - transatlonal 
nonenzymatic reaction and Is simply a function of the time 
integrated glucose concentration to which red cells are exposed. 
There is an excellant correlation between the percent of 
glycosylated hemoglobin and other indices of diabetic control. A 
number of studies have demonstrated quite convincingly that 
measurement of HbA^ is useful index of the degree of 
hyperglycemia present in diabetic patient over the previous 2 
mcnths or so . Koeing (1976) while controlling diabetic subjects 
noted that the decline in HbA, values followed the decline in 
blood glucose values within a 3-4 week delay and this delay is 
consistent with the fact that red cells high in HbA^ will continue 
to survive for several weeks. In normal Individual, the 
glycosylated hemoglobin may range from 3-6% whereas i t may 
increase to 8-12% In mild diabetics and upto 18-22% in more severe 
diabet ics . Measurement of HhA^ % may prove useful in screening 
large patient population for the presence of the unsuspected 
diabetes . Furthermore, the validi ty of the hemoglobin test does 
not require the pat ient ' s cooperation and does not depend on 
variables such as time of day, exercise or previous intake of 
food. 
Observations in experimental animals have provided 
valuable information on the relationship between glycosylated 
hemoglobin and diabetes. Koeing and Cerami (1975) have found 
that diabetic mice had increased levels of distinct minor 
hemoglobin component which like human HbA, had borohydride 
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reducible linkages on the ^-cha in . Koelng and his associates 
(1975) also fo-.u. : increased levels of HbA, in several strains 
of mice with chemically induced diabetes . Widness and his 
colleagues have found that glycosylated hemoglobin is increased 
in monkeys also when they become diabetic (referred In Bunn, 
1982). 
It i s quite ev ida i t from the instances quoted above 
that the significant increase in HbA^^ levels have been achieved 
after several weeks of hyperglycemic condition. However, in our 
studies we observed a significant increase in HbA. levels after 
4 days of treatment. Such significant change in HbA, values in 
such short span is unusual and not documented in the literature 
so far. In ear l ier studies by Taylor et a l . (1987), a • slight 
increase in HbA. was measured after 28 days (4 weeks) and 
marked increase after 56 days (8 weeks) and onwards following 
induction of diabetes. It is not clear from this study whether 
any short term sample was taken and if so whether i t showed 
only normal levels of HbA. . It i s also not clear from the 
li terature whether any other investigator attempted to carry out 
time dependent studies with respect to increase in HbA. following 
induction of diabetes . It appears to be generally presumed, 
without much of experimental evidence, that HbA. level will regis-
te r a significant r i se only following hyperglycemia for 
considerable per iod. If the increased HbA. concentration is the 
function of exposure of R.B.C. to elevated blood sugar without 
- 5 6 -
defining any minimum time duration, the results of the present 
invest igat iai . though unique, are not completely unexplainable. 
Further, if HbA. concentration i s proportional to degree of 
xc 
hyperglycemia, one would expect higher values in ra ts injected 
with single shot of StZ which register high glucose concentration. 
However, in our study the HbA^^ level are higher in the group 
administered with multiple doses of StZ which show relatively 
lesser magnitude of hyperglycemia. Even the comparison of the 
individual glucose levels with those of the corresponding HbA^ 
values also do not show any definite correlation. No plausible 
explanation to th is apparent anomalous situation can be offered 
at the moment. 
Diabetes is generally characterized by the deficiency 
of insulin which varies from an almost complete lack as seen in 
some with IDDM to a re la t ive deficiency observed in many with 
NIDDM who have a major component of insulin resistance. 
Approximately, 80% of those with NIDDM are obese and have 
var iable degrees of insulin resistance related to their obesi ty. 
It i s well documented from the animal studies that 
there is a significant decline in plasma InsuUn levels following 
"jtz induced diabetes . For instance, in male Wistar ra ts plasma 
insulin level declined from 31.5 pu/ml to 4.0 ^u/ml following 60 
mg/kg b .wt . administration of StZ (Klgoshl et a l . , 1986) and from 
188 pmoVL to 54 pmol/L following 65 mg/kg b .wt . administration 
of StZ (Pierce et a l . , 1989). in another study on CD-I mice, five 
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injections of StZ at a dose of 40 mg/kg b .wt . of StZ reduced the 
extractable insulin moderately but significantly (Like et a l . , 
1978). 
Hence, in the present s tudy, a distinct decline in 
plasma insulin levels following StZ treatmait is very much in 
keeping with the similar observations observed above. The 
decline is marked in multiple dose treated group than those admi-
nistered with single shot. The overall decrease, however, i s 
not as marked as reported by other investigators. This difference 
in the magnitude of response could well be due to source of 
insulin for generating antibodies. 
The islet cell specifically p -ce l l mass is reduced in 
number in most diabetic patients (Gepts and Le Compte, 1981). 
The degree of reduction and the precise pathologic picture 
depends on the type of diabetes and duration. In the present 
s tudy, the changes in plasma glucose, HbA. and plasma insuUn 
levels can be uorrelated with histological alterations in pancreatic 
i s l e t s . Architectural disarray of is lets which is also extending 
to the exocrine (acinar tissue) part , the Increase in intercellular 
space and per ipheral widening (between acinar and is let cells) 
are some of significant changes observed following StZ-treatment. 
Interestingly, a l l these changes are much more 
pronounced in single shot administered group than those of multiple 
dose treated ones. That StZ^,trea|r^^FftS-^pronounced effect on 
D^2-\19 
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i s le t cells i s further borne out by the significant reduction in 
the nuclear area of is le t cells which however appears almost 
similar in magnitude in single and multiple dose treated groups. 
It i s quite well documented that shortly after the 
onset of IDDM, the pancreas show an extensive infiltration of round 
inflammed cel ls (lymphocytes) - a condition called Insul l t is . 
Insulitis has also been observed in quite a few animal models 
following StZ treatment. In a time dependent study carried out 
by Like and Rossini (1976) to ascertain the appearance of insulitis 
in the mice following three intraperitoneal injections of StZ (40 
mg/kg/day), no insulitis could be observed after 1 injection, only 
moderate after 4-5 days and pronounced effect was noticed 6 days 
•^fter the completion of the last injection. In a latter study by 
the same author with prolonged treatment of 5 days, a more or 
less similar time dependent appearance of insulitis after about 
10 days following the initiation of the injections was observed 
(Like et a l . , 1978). Surprisingly, the same dose schedule, 
routes of administration and the timing of the killing failed to 
produce insulit is in 21 Charles River ra t s despite the fact that 
these animals became markedly hyperglycemic after single injection 
of StZ. In the present study, no trace of insulitis could be 
observed 4 days after the administration of StZ. This observed 
absence of insul i t is in our study may either be due to i t s 
altogether nonoccurrence in ra ts as has been observed by Like 
et a l . (1978) or due to short term duration of the present study. 
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The latter appears more likely though insuUtis, to the best of 
our knowledge, has not been reported in the rat model so far. 
Long term experiments are warranted to elucidate th is aspect . 
The hormonal and metabolic derangements of diabetes 
mellitus are reflected not only in disordered carbohydrate 
metabolism, but also in abnormal mobilization and transport of 
fat . The majority of newly diagnosed and untreated diabetics 
have elevated plasma lipoproteins which are the transport vehicles 
for lipids ( i . e . cholesterol, cholesterol es ters , t r iglycerides and 
phospholipids) in the blood stream. There are five complex 
lipoproteins that transport the major serum l ipids , chylomicrons, 
very low density lipoproteins (VLDL), low density lipoproteins 
(LDL), intermediate density lipoproteins (IDL) and high density 
lipoproteins (HDL). 
In view of the posit ive association between 
atherosclerosis and raised plasma levels of cholesterol and to 
a lesser extent t r ig lycer ides , plasma lipid abnormalities have 
attracted considerable in teres t . Eventhough the correlation 
between plasma lipid abnormalities and r i sk of atherosclerosis 
in diabetes is not very well documented, the measurement of lipid 
levels s t i l l forms an important indice In diabetic subjects. In 
the present s tudy, we have observed significant elevation In 
plasma cholestsrol levels following StZ treatment which is more 
marked in multiple dose treated group. A similar elevation in 
plasma cholesterol levels has also been observed by Pierce 
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et a l . (1989) following StZ treatment at the dose of 65 mg/kg 
b .vvt. 
From the management point of view, one of the most 
importait indices of severi ty of metaboUc disturbances in diabetes 
i s the degree of dehydration and electrolyte disturbances. In 
a diabetic kidney, hyaline deposition or increase In messangial 
mass has been noticed. However In the present study we have 
not observed any change in plasma osmolarity following StZ 
treatment. This observation also conforms with no apparent 
changes in the kidney histology in StZ treated r a t s . Possibly, 
the experimental duration was too short to have caused any 
discernible change in the fluid balance and renal architecture. 
To conclude, the present study brings out the following 
salient features -
( i) That StZ can cause significant experimental diabetes 
in albino ra ts at a dose of 45 mg/kg b .w t . which 
is perhaps the lowest reported dose. 
( i i ) There is no sex dependent vulnerability in the 
induction of diabetes . 
( i i l ) Evaluation of re la t ive efficacy of single versus 
multiple subdlabetogenic treatment of StZ reveal that 
single shot induces much greater hyperglycemia. 
Howe\'er, more marked changes in glycosylated 
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hemoglobin, plasma cholesterol and plasma Insulin 
levels are observed following multiple dose 
administration of StZ. 
( iv) A significant increase in HbA. is observed just after 
four days of hyperglycemic condition - a unique 
observation not documented in the li terature so far. 
(v) A highly significant architectural d isarray in 
panci'eatic is le t cells accompanied by marked shrinkage 
in the nuclear diameter which i s more pronounced 
in single shot StZ treatment and is quite in agreement 
with much higher hyperglycemia. 
(vi) No traces of insulit is nor any renal dysfunctioning 
evident from ei ther physiological or histological 
parameters. 
It i s evident that ti^p present study has made a 
significant contribution to lay the foundation of much needed base 
line data on animal model of diabetes. The stage is now set for 
experimenting with the newer and promising management strategies 
to control diabetes mellltus in teeming millions of global 
population. 
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